Copolymer Coating with Segmented Glass Transition Domains

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional methods for coating medical devices with therapeutic or diagnostic agents often lack controlled release mechanisms, leading to inefficient delivery of drugs to specific sites within the patient.

Innovation Solution

The use of copolymers with specific monomer units having different glass transition temperatures (Tgs) to form domains that trap and release therapeutic agents, allowing for controlled delivery by adjusting the Tg values to match physiological temperatures and optimize release profiles.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional coating methods are used to apply therapeutic agents to medical devices, then the coating process is simple, but the release of therapeutic agents is uncontrolled and inefficient

Engineering Contradiction:
Improvecontrolled release of therapeutic agentsVSAvoidcopolymer structure with different monomer units
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The copolymer is segmented into distinct domains with different glass transition temperatures. The first monomer unit forms domains with Tg near physiological temperature for controlled drug release, while the second monomer unit forms domains providing structural stability. This segmentation enables the coating to exhibit both controlled release behavior and mechanical integrity simultaneously.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention changes the physical-chemical parameters of the coating by selecting monomer units with specific glass transition temperatures. By adjusting the Tg of the first monomer unit to be within 10°C of physiological temperature and the second monomer unit to be at least 30°C higher, the coating's drug release profile and mechanical properties are precisely controlled through parameter selection rather than complex formulation.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If the copolymer is applied as a coating on the medical device, then drug delivery control is improved, but the manufacturing process becomes more complex compared to molding or packing

Engineering Contradiction:
Improveadherence of therapeutic agent to deviceVSAvoidcoating process versus molding or packing
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The copolymer is synthesized with predetermined monomer ratios and glass transition temperature characteristics before application to the device. This preliminary preparation ensures that the coating material inherently possesses the desired drug release profile and adherence properties, eliminating the need for complex post-application processing or adjustment steps during manufacturing.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The invention uses a composite copolymer structure combining two different monomer units with complementary properties. The first monomer provides temperature-responsive drug release characteristics, while the second monomer provides structural framework and adherence. This composite material approach enables both improved drug delivery control and reasonable manufacturability through a single coating application process.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances the adherence and release of therapeutic agents from medical devices, providing improved control over drug delivery and adherence to medical devices, facilitating more effective treatment.

Implementation Method 1

the copolymer comprises a first monomer unit and a second monomer unit, wherein the second monomer unit has a glass transition temperature that is at least about 30 degrees Centigrade higher than the glass transition temperature of the first monomer unit

Methodology Applied
Scientific EffectGlass transition temperature:

Data Source

PatentUSRE45500E1Polymeric network system for medical devices and methods of use
Publication Date: 2015.04.28 BIOINTERACTIONS LTD
  • USRE45500E1 patent drawing
  • USRE45500E1 patent drawing
  • USRE45500E1 patent drawing

AI summary

Methods of making a coating on a medical device are disclosed, including associating a composition with at least a portion of the device to form a layer. In some embodiments, a composition may include a copolymer prepared from a room temperature melt of a plurality of monomer units that comprises a first monomer unit and a second monomer unit, wherein the second monomer unit has a glass transition temperature that is at least about 30 degrees Centigrade higher than the glass transition temperature of the first monomer unit, with a glass transition temperature of a monomer unit being defined as a glass transition temperature of a homopolymer of that monomer unit.